S. Ebara

A mutated superantigen SEA D227A fusion diabody specific to MUC1 and CD3 in targeted cancer immunotherapy for bile duct carcinoma

K. Tsumoto, T. Kudo, I. Kumagai, 2002, Cancer Immunology, Immunotherapy.

Construction of a diabody (small recombinant bispecific antibody) using a refolding system.

K. Tsumoto, T. Kudo, I. Kumagai, 2000, Protein engineering.

A potential therapeutic role for small nonpeptidyl compounds that mimic human granulocyte colony-stimulating factor.

T. Taniyama, T. Kuwaki, T. Nishimura, 2004, Blood.

SEA-scFv as a bifunctional antibody: construction of a bacterial expression system and its functional analysis.

K. Tsumoto, Y. Hinoda, T. Kudo, 1999, Biochemical and biophysical research communications.

Alkali-tolerant high-activity catalase from a thermophilic bacterium and its overexpression in Escherichia coli.

Y. Shigemori, S. Ebara, 2008, Protein expression and purification.

FTR1335 is a novel synthetic inhibitor of Candida albicans N-myristoyltransferase with fungicidal activity.

Masataka Nakamura, H. Naito, K. Nakazawa, 2005, Biological & pharmaceutical bulletin.

Synthesis of potent and selective inhibitors of Candida albicans N-myristoyltransferase based on the benzothiazole structure.

K. Nakazawa, K. Yamazaki, S. Ebara, 2005, Bioorganic & medicinal chemistry.

Functional construction of the anti-mucin core protein (MUC1) antibody MUSE11 variable regions in a bacterial expression system.

K. Tsumoto, T. Kudo, I. Kumagai, 2000, Journal of biochemistry.